IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 3 filers reported holding IMPAX LABORATORIES INC in Q4 2011. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $86,000 | +17.8% | 4,407 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $73,000 | +14.1% | 4,407 | +38.8% | 0.00% | 0.0% |
Q3 2017 | $64,000 | +25.5% | 3,175 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $51,000 | +70.0% | 3,175 | +34.5% | 0.00% | – |
Q1 2017 | $30,000 | -3.2% | 2,360 | 0.0% | 0.00% | – |
Q4 2016 | $31,000 | -44.6% | 2,360 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $56,000 | -8.2% | 2,360 | +11.4% | 0.00% | 0.0% |
Q2 2016 | $61,000 | -10.3% | 2,119 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $68,000 | -25.3% | 2,119 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $91,000 | +175.8% | 2,119 | +122.8% | 0.00% | – |
Q3 2015 | $33,000 | +200.0% | 951 | +288.2% | 0.00% | – |
Q2 2015 | $11,000 | 0.0% | 245 | 0.0% | 0.00% | – |
Q1 2015 | $11,000 | -99.6% | 245 | -99.8% | 0.00% | -100.0% |
Q2 2014 | $2,999,000 | +41.9% | 100,000 | +25.0% | 0.09% | +35.4% |
Q1 2014 | $2,114,000 | -53.3% | 80,000 | -55.6% | 0.06% | -56.1% |
Q4 2013 | $4,525,000 | +844.7% | 180,000 | +480.6% | 0.15% | +770.6% |
Q1 2013 | $479,000 | +66.9% | 31,000 | +121.4% | 0.02% | +54.5% |
Q4 2012 | $287,000 | -91.8% | 14,000 | -89.6% | 0.01% | -92.2% |
Q3 2012 | $3,479,000 | -20.2% | 134,000 | -37.7% | 0.14% | -27.7% |
Q2 2012 | $4,358,000 | -19.4% | 215,000 | -2.3% | 0.20% | -20.1% |
Q1 2012 | $5,408,000 | +19.2% | 220,000 | -2.2% | 0.24% | +17.3% |
Q4 2011 | $4,538,000 | – | 225,000 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |